Medline Inc. (MDLN): Gross Profit
$7.52B
Year ended 2025-12-31
$7.84B
Trailing 12 months to 2026-06-27
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.52B | +7.8% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $6.98B | +18.5% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $5.88B | n/a | 2026-02-25, From 2023-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Medline Inc. (MDLN) | 2025-12-31 | $7.52B | +7.8% |
| Stryker Corp (SYK) | 2025-12-31 | $16.07B | +11.3% |
| 3M Co (MMM) | 2025-12-31 | $9.96B | -1.7% |
| Becton Dickinson & Co (BDX) | 2025-09-30 | $9.93B | +8.8% |
| Boston Scientific Corp (BSX) | 2025-12-31 | $13.85B | +20.6% |
| Baxter International Inc (BAX) | 2025-12-31 | $3.38B | -15.2% |
| Solventum Corp (SOLV) | 2025-12-31 | $4.45B | -3.1% |
| ResMed Inc (RMD) | 2026-06-30 | $3.45B | +13.0% |
| Dexcom Inc (DXCM) | 2025-12-31 | $2.80B | +14.9% |
Compare MDLN, SYK, MMM, BDX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗